272 related articles for article (PubMed ID: 22436377)
1. A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Kawabata T; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Hayashi YK; Nishino I; Momomura M; Kizawa T; Imagawa T; Yokota S
Brain Dev; 2012 Nov; 34(10):877-80. PubMed ID: 22436377
[TBL] [Abstract][Full Text] [Related]
2. Anti-signal recognition particle myopathy in the first decade of life.
Suzuki S; Ohta M; Shimizu Y; Hayashi YK; Nishino I
Pediatr Neurol; 2011 Aug; 45(2):114-6. PubMed ID: 21763952
[TBL] [Abstract][Full Text] [Related]
3. Unusual manifestations in two cases of necrotizing myopathy associated with SRP-antibodies.
Hanisch F; Müller T; Stoltenburg G; Zierz S
Clin Neurol Neurosurg; 2012 Sep; 114(7):1104-6. PubMed ID: 22306424
[TBL] [Abstract][Full Text] [Related]
4. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I
Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183
[TBL] [Abstract][Full Text] [Related]
5. [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia].
Itaya K; Inoue M; Iwanami H; Oonaka Y; Jimi T; Ichikawa H
Rinsho Shinkeigaku; 2015; 55(4):254-8. PubMed ID: 25904255
[TBL] [Abstract][Full Text] [Related]
6. Chronic Myopathy Associated With Anti-Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy.
Ikeda K; Mori-Yoshimura M; Yamamoto T; Sonoo M; Suzuki S; Kondo Y; Nakamura H; Mitsuhashi K; Maeda MH; Shimizu J; Hayashi YK; Nishino I; Oya Y; Murata M
J Clin Neuromuscul Dis; 2016 Jun; 17(4):197-206. PubMed ID: 27224434
[TBL] [Abstract][Full Text] [Related]
7. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).
Rojana-udomsart A; Mitrpant C; Bundell C; Price L; Luo YB; Fabian V; Wilton SD; Hollingsworth P; Mastaglia FL
J Neuroimmunol; 2013 Nov; 264(1-2):65-70. PubMed ID: 24041831
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.
Ma X; Xu L; Li Y; Bu B
BMC Cardiovasc Disord; 2021 Feb; 21(1):88. PubMed ID: 33579193
[TBL] [Abstract][Full Text] [Related]
10. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Arlet JB; Dimitri D; Pagnoux C; Boyer O; Maisonobe T; Authier FJ; Bloch-Queyrat C; Goulvestre C; Heshmati F; Atassi M; Guillevin L; Herson S; Benveniste O; Mouthon L
Neuromuscul Disord; 2006 May; 16(5):334-6. PubMed ID: 16616848
[TBL] [Abstract][Full Text] [Related]
11. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
[TBL] [Abstract][Full Text] [Related]
12. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
13. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.
Dimitri D; Andre C; Roucoules J; Hosseini H; Humbel RL; Authier FJ
Muscle Nerve; 2007 Mar; 35(3):389-95. PubMed ID: 17143889
[TBL] [Abstract][Full Text] [Related]
14. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T; Al-Lozi MT; Lopate G; Pestronk A
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
16. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies].
Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K
Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947
[TBL] [Abstract][Full Text] [Related]
17. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
18. [Myopericarditis in a case of anti-signal recognition particle (anti-SRP) antibody-positive myopathy].
Tanaka M; Gamou N; Shizukawa H; Tsuda E; Shimohama S
Rinsho Shinkeigaku; 2016 Dec; 56(12):862-865. PubMed ID: 27890880
[TBL] [Abstract][Full Text] [Related]
19. Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.
Wang L; Liu L; Hao H; Gao F; Liu X; Wang Z; Zhang W; Lv H; Yuan Y
Neuromuscul Disord; 2014 Apr; 24(4):335-41. PubMed ID: 24491486
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S
Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
